Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

Aoki, 1995, Therapeutic strategy for MRSA infections, 47

Shimada, 1995, Clinical summary of intravenous use of vancomycin hydrochloride for severe infection caused by methicillin-resistant Staphylococcus aureus, Jpn J Chemother, 43, 1048

Kaatz, 1990, Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis, J Infect Dis, 162, 103, 10.1093/infdis/162.1.103

Brunet, 1994, Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicaemia who recovered after administration of vancomycin, Eur J Clin Microbiol Infect Dis, 9, 145, 10.1007/BF01963643

Mainardi, 1995, Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus, J Infect Dis, 171, 1646, 10.1093/infdis/171.6.1646

Shlaes, 1995, Teicoplanin selects for Staphylococcus aureus that is resistant to vancomycin, Clin Infect Dis, 20, 1071, 10.1093/clinids/20.4.1071

Hiramatsu, 1997, Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility, 40, 135

Hiramatsu, 1996, Genetic basis for molecular epidemiology of MRSA, J Infect Chemother, 2, 117, 10.1007/BF02351563

1997

Hiramatsu, 1995, Molecular evolution of MRSA, Microbiol Immunol, 39, 531, 10.1111/j.1348-0421.1995.tb02239.x

Peterson, 1997, Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance, Clin Microbiol Rev, 5, 420, 10.1128/CMR.5.4.420

Berger-Bachi, 1986, Characterization of an isogenic set of methicillin-resistant and susceptible mutants of Staphylococcus aureus, Eur J Microbiol, 5, 697, 10.1007/BF02013308

Wada, 1993, Molecular cloning and mapping of 16S-23S rRNA gene complexes of Staphylococcus aureus, J Bacterial, 175, 7483, 10.1128/jb.175.22.7483-7487.1993

Courvalin, 1990, Resistance of enterococci to glycopeptides, Antimicrob Agents Chemother, 34, 2291, 10.1128/AAC.34.12.2291

Niitsuma, 1996, Vancomycin inhalation therapy-a pharmacokinetic and clinical study of vancomycin, Antibiot Chemother, 122, 123

Torres, 1979, Vancomycin concentration in human tissues: preliminary report, J Antimicrob Chemother, 5, 475, 10.1093/jac/5.4.475

Barber, 1964, Naturally occurring methicillin-resistant staphylococci, J Gen Microbiol, 35, 183, 10.1099/00221287-35-2-183

Dyke, 1969, Penicillinase production and intrinsic resistance to penicillins in methicillin-resistant cultures of Staphylococcus aureus, J Med Microbiol, 2, 261, 10.1099/00222615-2-3-261

Tanaka, 1995, A retrospective study of methicillin-resistant Staphylococcus aureus strains in Tokyo University Hospital, J Infect Chemother, 1, 40, 10.1007/BF02347728

Asada, 1995, Evolution and resistance expression of MRSA; evaluation of beta-lactam antibiotics against a set of isogenic strains with different types of phenotypic expression, Acta Biochimica Polanica, 42, 517, 10.18388/abp.1995_4905

1997, Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin, MMWR Morb Mortal WUy Rep, 46, 626

Hashimoto, 1994, A survey of Staphylococcus aureus for typing and drug-resistance in various areas of Japan during 1992 and 1993, Jpn J Antibiot, 47, 618

Daum, 1992, Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility, J Infect Dis, 166, 1066, 10.1093/infdis/166.5.1066

Sieradzki, 1997, Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus, J Bacterial, 179, 2557, 10.1128/jb.179.8.2557-2566.1997